DOCSLIB.ORG

National Model EMS Clinical Guidelines (NASEMSO)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Model EMS Clinical Guidelines (NASEMSO) National Model EMS Clinical Guidelines January 2019 VERSION 2.2 These guidelines will be maintained by NASEMSO to facilitate the creation of state and local EMS system clinical guidelines, protocols or operating procedures. System medical directors and other leaders are invited to harvest content as will be useful. These guidelines are either evidence-based or consensus- based and have been formatted for use by field EMS professionals. NASEMSO Medical Directors Council www.nasemso.org Contents INTRODUCTION .................................................................................................................................... 5 PURPOSE AND NOTES .......................................................................................................................... 6 TARGET AUDIENCE ....................................................................................................................................... 7 NEW IN THE 2017 EDITION ........................................................................................................................... 7 ACKNOWLEDGEMENTS .................................................................................................................................. 7 UNIVERSAL CARE ................................................................................................................................. 8 UNIVERSAL CARE GUIDELINE .......................................................................................................................... 8 FUNCTIONAL NEEDS ................................................................................................................................... 16 PATIENT REFUSALS ..................................................................................................................................... 20 CARDIOVASCULAR ............................................................................................................................. 23 ADULT AND PEDIATRIC SYNCOPE AND PRESYNCOPE ......................................................................................... 23 CHEST PAIN/ACUTE CORONARY SYNDROME (ACS)/ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) .... 27 BRADYCARDIA ........................................................................................................................................... 30 IMPLANTABLE VENTRICULAR ASSIST DEVICES .................................................................................................. 34 TACHYCARDIA WITH A PULSE ........................................................................................................................ 37 SUSPECTED STROKE/TRANSIENT ISCHEMIC ATTACK .......................................................................................... 43 GENERAL MEDICAL ............................................................................................................................ 46 ABDOMINAL PAIN ...................................................................................................................................... 46 ABUSE AND MALTREATMENT ....................................................................................................................... 49 AGITATED OR VIOLENT PATIENT/BEHAVIORAL EMERGENCY ............................................................................... 53 ANAPHYLAXIS AND ALLERGIC REACTION ......................................................................................................... 59 ALTERED MENTAL STATUS ........................................................................................................................... 64 BACK PAIN ................................................................................................................................................ 67 END-OF-LIFE CARE/PALLIATIVE CARE ............................................................................................................ 70 HYPERGLYCEMIA ........................................................................................................................................ 73 HYPOGLYCEMIA ......................................................................................................................................... 76 NAUSEA-VOMITING .................................................................................................................................... 80 PAIN MANAGEMENT .................................................................................................................................. 83 SEIZURES .................................................................................................................................................. 91 SHOCK ..................................................................................................................................................... 96 SICKLE CELL PAIN CRISIS ............................................................................................................................ 102 RESUSCITATION ............................................................................................................................... 105 CARDIAC ARREST (VF/VT/ASYSTOLE/PEA) .................................................................................................. 105 ADULT POST-ROSC (RETURN OF SPONTANEOUS CIRCULATION) CARE .............................................................. 114 DETERMINATION OF DEATH/WITHHOLDING RESUSCITATIVE EFFORTS ............................................................... 117 DO NOT RESUSCITATE STATUS/ADVANCE DIRECTIVES/HEALTHCARE POWER OF ATTORNEY (POA) STATUS ............. 120 TERMINATION OF RESUSCITATIVE EFFORTS ................................................................................................... 123 PEDIATRIC-SPECIFIC GUIDELINES ...................................................................................................... 128 BRIEF RESOLVED UNEXPLAINED EVENT (BRUE) ............................................................................................. 128 PEDIATRIC RESPIRATORY DISTRESS (BRONCHIOLITIS) ...................................................................................... 133 PEDIATRIC RESPIRATORY DISTRESS (CROUP) ................................................................................................. 138 NEONATAL RESUSCITATION ........................................................................................................................ 142 Updated November 23, 2020 2 OB/GYN ........................................................................................................................................... 146 CHILDBIRTH ............................................................................................................................................. 146 ECLAMPSIA/PRE-ECLAMPSIA ...................................................................................................................... 150 OBSTETRICAL AND GYNECOLOGICAL CONDITIONS .......................................................................................... 154 RESPIRATORY ................................................................................................................................... 157 AIRWAY MANAGEMENT ............................................................................................................................ 157 BRONCHOSPASM (DUE TO ASTHMA AND OBSTRUCTIVE LUNG DISEASE) ............................................................. 167 PULMONARY EDEMA ................................................................................................................................ 174 TRAUMA .......................................................................................................................................... 178 GENERAL TRAUMA MANAGEMENT .............................................................................................................. 178 BLAST INJURIES ........................................................................................................................................ 184 BURNS ................................................................................................................................................... 188 CRUSH INJURY ......................................................................................................................................... 192 EXTREMITY TRAUMA/EXTERNAL HEMORRHAGE MANAGEMENT ....................................................................... 195 FACIAL/DENTAL TRAUMA .......................................................................................................................... 200 HEAD INJURY ........................................................................................................................................... 203 HIGH THREAT CONSIDERATIONS/ACTIVE SHOOTER SCENARIO .......................................................................... 208 SPINAL CARE ........................................................................................................................................... 211 TOXINS AND ENVIRONMENTAL ........................................................................................................ 218 POISONING/OVERDOSE UNIVERSAL CARE ..................................................................................................... 218 ACETYLCHOLINESTERASE INHIBITORS (CARBAMATES, NERVE AGENTS, ORGANOPHOSPHATES) EXPOSURE ................ 226 RADIATION EXPOSURE
Load more

Recommended publications
  • Drug Interactions of Some Commonly Used Drugs in Dermatology
    Table Drug interactions of some commonly used drugs in dermatology M. J. Cyriac Department of Dermatology and Venereology, Medical College, Kottayam, India. Address for correspondence: Dr. M. J. Cyriac, Professor and Head, Department of Dermatology and Venereology, Medical College, Kottayam, India. E-mail: [email protected] Drug interactions leading to serious adverse effects are alternative medicines or food should also be borne in to be cautiously watched for when multiple drugs are mind.2 Increased risk of drug induced toxicity or used simultaneously.1 It is important for the physician therapeutic failure can occur when a new drug is added to be aware of these interactions. Although in many to a treatment regimen. It is impossible to remember instances the adverse interaction does not reach a all possible drug interactions. A ready to refer checklist magnitude of recognizable clinical expression, rarely is useful as a handy reference. it can result in a serious adverse outcome. Some of the commonly used drugs in dermatology and Adverse drug interactions may lead to increased their interactions, resultant clinical effect and possible toxicity, decreased efficacy or both. The possibility of underlying mechanisms are given in Table 1. Table 2 lists interaction with non-prescription drugs, herbal or the drugs with their relative risk for inducing interactions. Table 1: Drug interactions of some commonly used drugs Drug Interacting drug Adverse effect Remarks Erythromycin/Clarithromycin Theophylline Theophylline toxicity Precipitates
    [Show full text]
  • Prevention and Management of Heat-Related Illness
    PREVENTION AND MANAGEMENT OF HEAT-RELATED ILLNESS Federal Bureau of Prisons Clinical Guidance DECEMBER 2017 Federal Bureau of Prisons (BOP) Clinical Guidance is made available to the public for informational purposes only. The BOP does not warrant this guidance for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases are evaluated on an individual basis and that treatment decisions are patient- specific. Consult the BOP Health Management Resources Web page to determine the date of the most recent update to this document: http://www.bop.gov/resources/health_care_mngmt.jsp Federal Bureau of Prisons Prevention and Management of Heat-Related Illness Clinical Guidance December 2017 TABLE OF CONTENTS 1. PURPOSE AND OVERVIEW ......................................................................................................................1 2. PATHOPHYSIOLOGY...............................................................................................................................1 3. RISK FACTORS FOR HRI ........................................................................................................................2 4. SYMPTOMS AND SIGNS ..........................................................................................................................3 5. EVALUATION.........................................................................................................................................5 6. TREATMENT..........................................................................................................................................6
    [Show full text]
  • A Case Report: What Is the Real Cause of Death from Acute Chlorine Exposure in an Asthmatic Patient? Toprak S1 and Kalkan EA2*
    Toprak and Kalkan. Int J Respir Pulm Med 2016, 3:045 International Journal of Volume 3 | Issue 2 ISSN: 2378-3516 Respiratory and Pulmonary Medicine Case Report: Open Access A Case Report: What is the Real Cause of Death from Acute Chlorine Exposure in an Asthmatic Patient? Toprak S1 and Kalkan EA2* 1Forensic Medicine Department, Bulent Ecevit University, Turkey 2Forensic Medicine Department, Canakkale Onsekiz Mart University, Turkey *Corresponding author: Esin Akgul Kalkan, MD, Assistant Professor, Canakkale Onsekiz Mart University, Faculty of Medicine, Forensic Medicine Department, Canakkale Onsekiz Mart Universitesi, Tip Fakultesi, Adli Tip Anabilim Dali, 17020, Canakkale, Turkey, Tel: +90 532 511 12 97, +90 286 218 00 18/2777, E-mail: [email protected] with a mixture of various chemicals including bleach and an acid Abstract containing product (hydrochloric acid). According to witnesses, her This case report presents an acute and chronic inflammation symptoms include cough, shortness of breath along with red tearing process at the same time and resulted in death following exposure eyes. She is a non-smoker and has no significant medical history other to chlorine gas. A 65-years-old woman died shortly after cleaning than asthma. She was declared dead when she arrives to hospital. her bathroom with a mixture of various chemicals including bleach and an acid containing product. She was declared dead when she The decedent was 155 cm tall and weighed 67 kg. The external arrives to hospital. She is a non-smoker and has no significant findings were unremarkable. Internally the left and right lungs medical history other than asthma.
    [Show full text]
  • DRI® Digoxin Assay
    DRI® Digoxin Assay For In Vitro Diagnostic Use 1669 (25 mL, 8 mL Kit) 1669-A (25 mL, 8 mL Kit) Intended Use Reagent Preparation and Storage The DRI® Digoxin Assay is intended for the quantitative determination of digoxin in human The reagents are ready for use. No reagent preparation is required. All assay components, serum or plasma. when stored properly at 2-8°C, are stable until the expiration date indicated on the label. Summary and Explanation of the Test Specimen Collection and Handling Digitalis is known to have the ability to increase the force and velocity of myocardial Pharmacokinetic factors, such as dosage form, mode of administration, concomitant drug therapy contraction.1 Digoxin is one of the most commonly used forms of digitalis in the treatment as well as the patient’s clinical condition may influence the correct time of sample collection.2,3 For of congestive heart failure and arrhythmia such as atrial fibrillation and atrial flutter. The reliable interpretation of results, a serum specimen should be collected 6 to 8 hours following therapeutic range of digoxin is narrow. Futhermore, individual differences in drug absorption, the last oral dose of digoxin. Either serum or heparin and EDTA treated plasma samples can distribution, metabolism, and excretion as well as factors such as concurrent use of other drugs be used with the assay. Samples may be stored refrigerated at 2-8°C for up to 7 days or frozen and illness can also alter the serum concentration in response to a given dosage. Monitoring (-20°C) for up to 6 months.
    [Show full text]
  • Environmental Issues in Sports Medicine Jeremiah Penn, MD Sanford Orthopedics and Sports Medicine Bismarck, ND Lecture Objectives
    Environmental Issues in Sports Medicine Jeremiah Penn, MD Sanford Orthopedics and Sports Medicine Bismarck, ND Lecture Objectives Identify common environmental illnesses Describe prevention of environmental illness Describe treatment for life-threatening and non-emergent environmental illness Mt Everest 29,029 ft above sea level First climbed by Edmund Hillary and Tenzing Norgay on May 29, 1953 Number of summits in 1975: 15 Number of summits in 1995: 83 Number of summits in 2004: 330 Number of summits in 2010: 513 Introduction Outdoor sports are increasing in popularity Participants are becoming more “extreme” Family physicians need to be able to recognize and treat these problems in their patient population Environmental Illness Heat related Illness Cold injury Altitude UV Light Lightning Heat related Illness Heat edema Heat rash Heat syncope Heat cramps Heat exhaustion Heat stroke Human Heat Loss Convection Conduction Evaporation Radiation Chicago Marathon 2007 Wet Bulb Globe Temperature Developed by USMC in 1956 at Parris Island, SC Takes into account temperature, humidity, wind speed, and solar radiation WBGT = 0.7Tw + 0.2Tg + 0.1Td Wet Bulb Globe Temperature Category Temperature (°F) Flag 1 <79.9 None 2 80 – 84.9 Green 3 85 – 87.9 Yellow 4 88 – 89.9 Red 5 ≥90 Black Heat Index Chart Developed by RG Steadman in 1979 Takes into account temperature and relative humidity Much easier to calculate, don’t need special equipment Heat Edema Transient venodilation to facilitate core heat loss Normal body temperature
    [Show full text]
  • Master's Thesis Electronic Gatekeeper Using ETHERNET
    University of West Bohemia Faculty of Applied Sciences Department of Computer Science and Engineering Master’s thesis Electronic Gatekeeper using ETHERNET Plzeň 2019 Hamza Elghoul Místo této strany bude zadání práce. Declaration I hereby declare that this master’s thesis is completely my own work and that I used only the cited sources. Plzeň, 2 May 2018 Hamza Elghoul Abstract The aim of this thesis is the analysis and the realization of a budget 2-way communication system using ETHERNET connection, more specific- ally a door intercom station (hereinafter ”Bouncer” or "Gatekeeper"), where it is possible to make voice calls between two CLIENTS, a CALLER and a CALLEE with an acceptable to minimal delay. There are many alternative methods available for implementing such sys- tems, this project will try to compare some of these solutions and choose the most convenient platform according to a number of factors, such as band- width, processing power needed and communication protocols in question. Keywords: VoIP, SIP,SDP, server, client, LAN, ethernet, embedded, audio, raspberry pi Contents Page List of Figures7 1 Preface 10 2 Analysis 11 2.1 Objectives and Requirements................. 11 2.2 Hardware............................ 12 2.2.1 Arduino......................... 12 2.2.2 RaspberryPi 3 Model B................ 13 2.2.3 Banana Pi........................ 14 2.2.4 Orange Pi........................ 15 2.2.5 CubieBoard 2...................... 16 2.2.6 Beagle Bone Black................... 16 2.3 Application........................... 18 2.4 Audio capture and digitalisation................ 19 2.4.1 Signaling Protocols................... 20 2.5 Communication Protocol.................... 23 2.5.1 Session Initiation Protocol............... 23 2.5.2 Real Time Protocol..................
    [Show full text]
  • Tourniquet Use in Out-Of-Hospital Emergency Care: a Systematic Review
    Emergencias 2019;31:47-54 REVIEW ARTICLE Tourniquet use in out-of-hospital emergency care: a systematic review Mara Alonso-Algarabel 1, Xavier Esteban-Sebastià 2, Azucena Santillán-García 3, Rafael Vila-Candel 4,5 Objective. Uncontrolled bleeding from serious injuries continues to be one of the main causes of preventable deaths Author affiliation: 1Surgery Unit and Outpatient, outside hospitals. Tourniquets could be useful for quickly stemming blood flow and prevent exsanguination, although Hospital Universitario Miguel evidence supporting their use and effectiveness in civilian accidents is limited. To analyze the effectiveness of tourni - Servet, Zaragoza, Spain. quets for stopping bleeding in out-of-hospital emergencies and to explore factors associated with effectiveness. 2Emergency Department, Hospital Comarcal Vinarós, Castellón, Methods. We undertook a systematic review of the literature in Spanish and English. Search protocols to identify Spain 3 studies that evaluated the use of various devices and their effectiveness in stemming arterial blood flow. We included Cardiology Department, Hospital Universitario de Burgos, Burgos, studies published between 2011 and 2016 in which tourniquets were used to prevent massive blood loss. Spain 4Department of Obstetrics and Results. We included 17 articles. Tourniquets were effective in stopping massive bleeding in all studies. Pain, the most Gynecology, Hospital Universitario frequently described adverse effect, was observed in 420 patients (35.7%). Delayed application of a tourniquet was de la Ribera, Alzira, Valencia, associated with more negative outcomes. Spain. 5Nursing Department, Conclusions. Tourniquets are effective for stopping massive blood loss. There are few complications, most of which are Universidad Católica de Valencia attributable to the critical state of patients rather than to application of the tourniquet.
    [Show full text]
  • A Profile of Out-Of-Hospital Cardiac Arrests in Northern Emirates, United Arab Emirates
    A profile of out-of-hospital cardiac arrests in Northern Emirates, United Arab Emirates Alan M. Batt, MSc(c), Ahmed S. Al-Hajeri, BHSc EMHCA, Fergal H. Cummins, MB, MSc (DM). ABSTRACT Results: A total of 384 patients were enrolled in this study. Male victims of out-of-hospital cardiac arrest represented 76% of the participants. The mean age اﻷهداف: دراسة خصائص ضحايا السكتات القلبية خارج of the study population was 50.9 years. An over-all املستشفى واملخرجات في إمارات الشارقة ورأس اخليمة وأم prehospital return of spontaneous circulation rate القيوين والفجيرة وعجمان. of 3.1% was documented, as well as a 30% rate of bystander cardiopulmonary resuscitation being performed. Public access defibrillators were applied in الطريقة:هذه دراسة وصفية استباقية ملجموعة من حاﻻت of cases. Data is presented according to Utstein %0.5 سكتات القلب خارج املستشفى والتي نقلها طواقم اﻹسعاف .reporting criteria الوطني في الفترة من فبراير 2014 حتى مارس 2015. Conclusion: Baseline data for out-of-hospital النتائج: تناولت الدراسة 384 حالة.شكلت %76 من احلاﻻت cardiac arrest was established for the first time in the Northern Emirates of the United Arab Emirates. A ذكور اصيبوا بسكتات قلبية. متوسط العمر ملجموعة البحث هو low survival rate for out-of-hospital cardiac arrest, low 50.9 سنة. نسبة استعادة الدورة الدموية التلقائية التي ُوثقت rates of bystander cardiopulmonary resuscitation, and كانت %3.1 إلى جانب توثيق نسبة %30 من اﻹنعاش القلبي .low public access defibrillator use were discovered الرئوي الذي قام به حاضرون في مكان احلدث. ُاستعني بأجهزة Although low by comparison to established western إزالة الرجفان البطيني اخلارجية املتاحة للجمهور في %0.5 من systems results are similar to other systems in the احلاﻻت وعرضت البيانات وفق مقاييس أوتستاين للتقارير.
    [Show full text]
  • Saving Smiles Avulsion Pathway (Page 20) Saving Smiles: Fractures and Displacements (Page 22)
    Greater Manchester Local Dental Network SavingSmiles Improving outcomes following dental trauma First Edition I Spring 2017 Practitioners’ Toolkit Contents 04 Introduction to the toolkit from the GM Trauma Network 06 History & examination 10 Maxillo-facial considerations 12 Classification of dento-alveolar injuries 16 The paediatric patient 18 Splinting 20 The AVULSED Tooth 22 The BROKEN Tooth 23 Managing injuries with delayed presentation SavingSmiles 24 Follow up Improving outcomes 26 Long term consequences following dental trauma 28 Armamentarium 29 When to refer 30 Non-accidental injury 31 What should I do if I suspect dental neglect or abuse? 34 www.dentaltrauma.co.uk 35 Additional reference material 36 Dental trauma history sheet 38 Avulsion pathways 39 Fractues and displacement pathway 40 Fractures and displacements in the primary dentition 41 Acknowledgements SavingSmiles Improving outcomes following dental trauma Ambition for Greater Manchester Introduction to the Toolkit from The GM Trauma Network wish to work with our colleagues to ensure that: the GM Trauma Network • All clinicians in GM have the confidence and knowledge to provide a timely and effective first line response to dental trauma. • All clinicians are aware of the need for close monitoring of patients following trauma, and when to refer. The Greater Manchester Local Dental Network (GM LDN) has established a ‘Trauma Network’ sub-group. The • All settings have the equipment described within the ‘armamentarium’ section of this booklet to support optimal treatment. Trauma Network was established to support a safer, faster, better first response to dental trauma and follow up care across GM. The group includes members representing general dental practitioners, commissioners, To support GM practitioners in achieving this ambition, we will be working with Health Education England to provide training days and specialists in restorative and paediatric dentistry, and dental public health.
    [Show full text]
  • Pathophysiological Mechanisms of Root Resorption After Dental Trauma: a Systematic Scoping Review Kerstin M
    Galler et al. BMC Oral Health (2021) 21:163 https://doi.org/10.1186/s12903-021-01510-6 RESEARCH ARTICLE Open Access Pathophysiological mechanisms of root resorption after dental trauma: a systematic scoping review Kerstin M. Galler1*, Eva‑Maria Grätz1, Matthias Widbiller1 , Wolfgang Buchalla1 and Helge Knüttel2 Abstract Background: The objective of this scoping review was to systematically explore the current knowledge of cellular and molecular processes that drive and control trauma‑associated root resorption, to identify research gaps and to provide a basis for improved prevention and therapy. Methods: Four major bibliographic databases were searched according to the research question up to Febru‑ ary 2021 and supplemented manually. Reports on physiologic, histologic, anatomic and clinical aspects of root resorption following dental trauma were included. Duplicates were removed, the collected material was screened by title/abstract and assessed for eligibility based on the full text. Relevant aspects were extracted, organized and summarized. Results: 846 papers were identifed as relevant for a qualitative summary. Consideration of pathophysiological mechanisms concerning trauma‑related root resorption in the literature is sparse. Whereas some forms of resorption have been explored thoroughly, the etiology of others, particularly invasive cervical resorption, is still under debate, resulting in inadequate diagnostics and heterogeneous clinical recommendations. Efective therapies for progres‑ sive replacement resorptions have not been established. Whereas the discovery of the RANKL/RANK/OPG system is essential to our understanding of resorptive processes, many questions regarding the functional regulation of osteo‑/ odontoclasts remain unanswered. Conclusions: This scoping review provides an overview of existing evidence, but also identifes knowledge gaps that need to be addressed by continued laboratory and clinical research.
    [Show full text]
  • VA/Dod Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury
    VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CONCUSSION-MILD TRAUMATIC BRAIN INJURY Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard of care and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. This Clinical Practice Guideline is based on a systematic review of both clinical and epidemiological evidence. Developed by a panel of multidisciplinary experts, it provides a clear explanation of the logical relationships between various care options and health outcomes while rating both the quality of the evidence and the strength of the recommendation. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. These guidelines are not intended to represent TRICARE policy. Further, inclusion of recommendations for specific testing and/or therapeutic interventions within these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 2.0 – 2016 VA/DoD Clinical Practice Guideline for the Management of Concussion-mild Traumatic Brain Injury Prepared by: The Management of Concussion-mild Traumatic Brain Injury Working Group With support from: The Office of Quality, Safety and Value, VA, Washington, DC & Office of Evidence Based Practice, U.S.
    [Show full text]
  • Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters
    European Journal of Human Genetics (2019) 26:820–1023 https://doi.org/10.1038/s41431-018-0248-6 ABSTRACT Abstracts from the 50th European Society of Human Genetics Conference: Electronic Posters Copenhagen, Denmark, May 27–30, 2017 Published online: 1 October 2018 © European Society of Human Genetics 2018 The ESHG 2017 marks the 50th Anniversary of the first ESHG Conference which took place in Copenhagen in 1967. Additional information about the event may be found on the conference website: https://2017.eshg.org/ Sponsorship: Publication of this supplement is sponsored by the European Society of Human Genetics. All authors were asked to address any potential bias in their abstract and to declare any competing financial interests. These disclosures are listed at the end of each abstract. Contributions of up to EUR 10 000 (ten thousand euros, or equivalent value in kind) per year per company are considered "modest". Contributions above EUR 10 000 per year are considered "significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal and fetal echocardiography. The molecular karyotyping Genetics revealed a gain in 8p11.22-p23.1 region with a size of 27.2 Mb containing 122 OMIM gene and a loss in 8p23.1- E-P01.02 p23.3 region with a size of 6.8 Mb containing 15 OMIM Prenatal diagnosis in a case of 8p inverted gene. The findings were correlated with 8p inverted dupli- duplication deletion syndrome cation deletion syndrome. Conclusion: Our study empha- sizes the importance of using additional molecular O¨. Kırbıyık, K. M. Erdog˘an, O¨.O¨zer Kaya, B. O¨zyılmaz, cytogenetic methods in clinical follow-up of complex Y.
    [Show full text]